CoChat

Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective

Collins, Nancy, Tighe, Ann P., Brunton, Stephen A., Kris-Etherton, Penny M. · 2008 · Journal of the American College of Nutrition

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Abstract

The medical management of many diseases and conditions can include either restriction or provision of specific essential nutrients. When such nutrients are needed, there are often both prescription and nonprescription products available, as in the case of nicotinic acid or omega-3 fatty acids. Although they may seem to contain similar ingredients, there may be important differences between the prescription and dietary-supplement preparations. The manufacturing of prescription pharmaceutical products is regulated by the US Food and Drug Administration (FDA), which mandates standards for consistency and quality assurance. Dietary supplements are available to consumers under the provisions of the Dietary Supplement Health and Education Act of 1994, for which the FDA has the burden of proving a dietary supplement is harmful rather than requiring the manufacturer prove that the supplement is safe. Consumers and medical professionals should be aware of the important qualitative and quantitative differences between the FDA-approved prescription formulations and dietary supplements, particularly when an essential nutrient is part of the medical management of a disease or condition.

Overview

Integrity signals

Registry

Crossref · 10.1080/07315724.2008.10719743

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 7

  1. 2005, Vitamin Supplements., 1213, 57
  2. 2004, FDA Announces Qualified Health Claims for Omega-3 Fatty Acids., 1
  3. 1989, Lancet, 2, 757
  4. 2003, Cardiovasc Rev Rep, 24, 520
  5. 2005, US Pharmacist, 30, 61
  6. 1994, Eur J Clin Nutr, 48, 859
  7. 2006, Med Lett Drugs Ther, 48, 59

Cited by

See all 44

Metadata

Authors
Collins, N., Tighe, A. P., Brunton, S. A., & Kris-Etherton, P. M.
Affiliations
Cabarrus College of Health Sciences (US)
Venue
Journal of the American College of Nutrition
Published
2008-12
Volume
27
Issue
6
Pages
659-666
ISSN
  • 0731-5724 (ISSN-L)
  • 1541-1087
OpenAlex
W2043152421
Cited by
44
References
41
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 1 · 2016: 2 · 2015: 1 · 2014: 6 · 2013: 6 · 2012: 4
FWCI
0.24
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American College of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
Keywords
omega-3 fatty acids, dietary supplements, prescription drugs, FDA regulation, Dietary Supplement Health and Education Act of 1994, essential nutrients, nicotinic acid, quality assurance, regulatory burden
MeSH terms
Hypolipidemic Agents, Pharmaceutical Preparations, Nonprescription Drugs, Humans, Legislation, Drug, Legislation, Food, United States, United States Food and Drug Administration, Hypertriglyceridemia, Fatty Acids, Omega-3, Dietary Supplements, Prescription Drugs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective. https://app.cochat.ai/papers/10.1080/07315724.2008.10719743
The paper
Collins, N., Tighe, A. P., Brunton, S. A., & Kris-Etherton, P. M. (2008). Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective. Journal of the American College of Nutrition. https://doi.org/10.1080/07315724.2008.10719743

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.